American Joint Committee on Cancer Clinical Stage as a Selection Criterion for Sentinel Lymph Node Biopsy in Thin Melanoma

@article{Vaquerano2006AmericanJC,
  title={American Joint Committee on Cancer Clinical Stage as a Selection Criterion for Sentinel Lymph Node Biopsy in Thin Melanoma},
  author={Julio E Vaquerano and William G. Kraybill and Deborah L. Driscoll Ba and Richard T. Cheney and John M. Kane},
  journal={Annals of Surgical Oncology},
  year={2006},
  volume={13},
  pages={198-204}
}
A significant proportion of newly diagnosed melanomas are thin lesions (≤1.00 mm). Because tumor thickness correlates with the risk for nodal metastases, sentinel lymph node (SLN) biopsy in this subset is controversial. Incorporating other prognostic factors (Clark level and ulceration), we evaluated the 6th edition American Joint Committee on Cancer (AJCC) clinical stage as a simple and widely applicable guideline for offering SLN biopsy for thin melanoma. This study was a review of a… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 45 REFERENCES

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2001
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results

RJ Vuylsteke, PA van Leeuwen, MG Statius Muller
  • J Clin Oncol
  • 2003
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Cost-effectiveness of sentinel lymph node biopsy in thin melanomas

DM Agnese, SF Abdessalam, WE JrBurak
  • Surgery
  • 2003
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2003
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…